ema prac naion semaglutide june 2025 Last month, the European Medicines Agency recommended that product information for #semaglutide medicines— the active ingredient in #Ozempic, #Rybelsus, and #Wegovy — be updated to include non-arteritic anterior ischemic optic neuropathy or # Ischemic Optic Neuropathy Treatment Market

This dual pathway therapy brings together two mechanisms in one medication and is offered as a compounded prescription for eligible patients, supporting a more modern, clinician guided approach to individualized metabolic care

A formulation change was also mentioned by some reviewers as affecting perceived efficacy

It is a drug that we anticipate will require long-term use, Hurtado Andrade adds

Missing doses or extending the interval beyond seven days can allow GLP-1 receptor activation to decline, potentially reducing appetite suppression and weight loss momentum

Compounded Liraglutide Shortage status: Liraglutide remains on the FDA shortage list as of May 2026, distinct from semaglutide and tirzepatide

Particle size, polydispersity coefficient (PDI), and zeta potential under nanoparticle size analyzer, and encapsulation efficiency were determined according to the method in Determination of liposome encapsulation rate and drug loading capacity